Regulation And Legal
Aarti Drugs Subsidiary Receives US FDA Form 483
Aarti Drugs Ltd discloses its subsidiary Pinnacle Life Science received 3 observations in a US FDA Form 483 after a facility inspection.
The observations, received on November 6, 2026, are not related
